| Followers | 7 |
| Posts | 735 |
| Boards Moderated | 0 |
| Alias Born | 03/19/2011 |
Saturday, November 03, 2018 8:55:11 PM
Now that I've had more time to do due diligence, I'm more cautious. "Ginkgo Bioworks also accounted for 40% and 32% of our revenue for the nine months ended June 30, 2017 and 2018, respectively." ....Negative gross margins. ....and IR was unhelpful and dismissive of my questions...A vibe I personally cannot ignore. Entirely possible they were just having a bad day.
Good DD.... https://www.nanalyze.com/2018/10/twist-bioscience-stock-ipo/
Good DD.... https://www.nanalyze.com/2018/10/twist-bioscience-stock-ipo/
Recent TWST News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/27/2026 08:26:30 PM
- Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference • Business Wire • 05/27/2026 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/26/2026 08:15:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 08:05:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 08:05:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 08:05:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 08:05:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 08:05:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 08:05:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/26/2026 07:41:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/26/2026 01:43:01 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/21/2026 08:42:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/21/2026 08:33:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/21/2026 08:30:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/21/2026 08:26:32 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/21/2026 07:54:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/21/2026 07:31:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/12/2026 08:05:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/08/2026 04:25:46 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/07/2026 09:07:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:05:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:05:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:05:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:05:10 PM
- Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) • Business Wire • 05/05/2026 12:00:00 PM
